Showing results (41-50 of 505) with videos related to
Sort By:
Pageof 51
Acta Biomaterialia|June 22, 2019
The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problemIqbal H Jaffer, Jeffrey I WeitzThrombosis and Haemostasis|February 27, 2019
Long-Term Management of Venous Thromboembolism: Lessons from EINSTEIN CHOICE and Other Extension TrialsJeffrey I Weitz, Noel C ChanAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
New anticoagulants: current status and future potentialJeffrey I Weitz, Mark A CrowtherHematology. American Society of Hematology. Education Program|December 13, 2012
New oral anticoagulants: which one should my patient use?Jeffrey I Weitz, Peter L GrossFuture Cardiology|February 20, 2019
Rivaroxaban for prevention and treatment of venous thromboembolismNoel C Chan, Jeffrey I WeitzJournal of Thrombosis and Haemostasis : JTH|April 28, 2023
News at XI: moving beyond factor Xa inhibitorsJames C Fredenburgh, Jeffrey I WeitzCurrent Treatment Options in Cardiovascular Medicine|September 16, 2010
New and emerging anticoagulant therapies for venous thromboembolismLori-Ann Linkins, Jeffrey I WeitzSeminars in Thrombosis and Hemostasis|January 14, 2004
New anticoagulantsLori-Ann Linkins, Jeffrey I WeitzCardiovascular Toxicology|April 2, 2003
Direct thrombin inhibitors in cardiac diseaseJeffrey I Weitz, Eric R BatesExpert Opinion on Investigational Drugs|April 23, 2004
Ximelagatran: the first oral direct thrombin inhibitorMark A Crowther, Jeffrey I WeitzPageof 51